Melanoma Treatment Best Hospitals China 2026

OrientHealthLink · Cost Guide · Updated October 2026

Melanoma Treatment Best Hospitals China 2026: Costs, Top Cancer Centers, and How to Choose

By the OrientHealthLink Research Team · 12 min read

If you or someone you love has just heard the word "melanoma," you are probably juggling fear, confusion, and a stack of information that doesn't quite add up. You may have been told the treatment is effective — but that it costs more than your home, your savings, or your retirement combined. You are not alone in that. Every year, thousands of international patients begin searching for melanoma treatment in China precisely because the numbers at home feel impossible.

This guide is written to help you make a calm, informed decision. We will walk through which hospitals in China genuinely lead in melanoma care in 2026, what treatment actually costs, how immunotherapy access works, and — most importantly — how to avoid the clinics that look impressive online but lack real melanoma expertise. If you want to understand how we independently vet hospitals before recommending them, see how we choose hospitals.

Why Patients Travel to China for Melanoma Treatment in 2026

Melanoma is one of the most treatable cancers when caught early — and one of the most expensive to treat when it isn't. According to the World Health Organization, melanoma incidence continues to rise globally, and the cost of advanced therapies has become a defining barrier to care in the US, UK, and Australia.

China has become a serious destination for melanoma care for three reasons. First, its top cancer hospitals are high-volume centers that treat thousands of melanoma patients per year, giving surgical and medical oncology teams deep, repeated experience. Second, China's domestic pharmaceutical industry has produced PD-1 inhibitors — toripalimab, sintilimab, camrelizumab — that are clinically comparable to Western counterparts at a fraction of the price. Third, waiting times are short: most international patients can begin treatment within one to three weeks of first contact.

The result is a care pathway that is fast, technically advanced, and dramatically more affordable than the same treatment in the US, UK, or Australia. What it is not is uniform — hospital quality varies widely, which is why careful selection matters more here than almost anywhere else.

What Melanoma Treatment Actually Involves in 2026

Before comparing hospitals, it helps to understand what "melanoma treatment" means in practice. For early-stage melanoma (Stage I–II), the standard approach is wide local excision — removing the tumor with a safety margin — often combined with sentinel lymph node biopsy (SLNB) to check whether cancer has spread to nearby lymph nodes.

For Stage III melanoma, treatment typically adds immunotherapy (PD-1 inhibitors, sometimes combined with CTLA-4 inhibitors like ipilimumab) and may include lymph node dissection. For Stage IV or metastatic melanoma, systemic therapy dominates: immunotherapy combinations, BRAF/MEK targeted therapy for BRAF-mutant tumors, and in select cases, radiation or surgery for symptom control.

Modern melanoma care is therefore a team sport — it requires dermatopathologists, surgical oncologists, medical oncologists, radiologists, and increasingly molecular pathologists who can run BRAF, NRAS, and KIT mutation testing. A hospital that is excellent at, say, liver cancer may still be mediocre at melanoma if it lacks this specific multidisciplinary infrastructure. This is the single most important thing to verify.

The Best Hospitals in China for Melanoma Treatment (2026)

Based on published outcomes, departmental specialization, international patient infrastructure, and clinical trial activity, the following hospitals consistently rank among the strongest melanoma centers in China for 2026. You can explore a broader list of vetted facilities on our hospital directory.

Peking Union Medical College Hospital (Beijing) — Widely considered China's flagship academic hospital, Peking Union combines rigorous diagnostic pathology with a strong multidisciplinary tumor board. It is an excellent choice for complex or diagnostically uncertain melanoma cases.

Fudan University Shanghai Cancer Center (Shanghai) — One of Asia's largest dedicated cancer hospitals. Its melanoma and soft-tissue sarcoma program is among the most active in clinical trials, giving patients access to novel immunotherapies not yet available elsewhere.

Sun Yat-sen University Cancer Center (Guangzhou) — A national leader in immunotherapy research, with high-volume experience in PD-1 and combination regimens. Particularly strong for advanced and metastatic melanoma.

Beijing Cancer Hospital (Peking University) — A dedicated oncology institution with deep expertise in surgical oncology and molecular testing. Frequently chosen by international patients seeking surgery plus adjuvant immunotherapy.

Zhongshan Hospital, Fudan University (Shanghai) — Known for integrated surgical and medical oncology care, with efficient international patient services and English-speaking coordinators.

Cost Comparison: Melanoma Treatment in China vs US, UK, and Australia

Cost is usually the reason patients start searching, so let's put real 2026 numbers on the table. The figures below are typical self-pay estimates for international patients at top-tier Chinese cancer centers, compared with published pre-insurance costs in the US and private costs in the UK and Australia.

Putting it together: a patient needing surgery plus one year of adjuvant PD-1 immunotherapy would typically pay USD 20,000–45,000 in China, versus USD 180,000–350,000 in the US before insurance. Even accounting for travel and accommodation, the savings are substantial — often enough to cover a full year of follow-up care. For a deeper breakdown of how Chinese hospital pricing works, see our pricing guide.

It's worth being honest: the very lowest quoted prices you'll see online often come from hospitals that lack melanoma-specific expertise. The numbers above reflect top-tier academic centers — the ones you actually want.

Immunotherapy Access: The Real Story in China

Immunotherapy has transformed melanoma survival. In 2026, Chinese hospitals offer the full international toolkit: pembrolizumab (Keytruda), nivolumab (Opdivo), ipilimumab (Yervoy), and the combination of nivolumab plus relatlimab. They also offer domestically developed PD-1 inhibitors — toripalimab, sintilimab, camrelizumab, and tislelizumab — several of which have been approved by the FDA and are used in global trials.

In practice, patients often receive a domestically produced PD-1 inhibitor at 40–60% lower cost than the imported equivalent, with comparable efficacy in published studies. This is a legitimate, evidence-based choice, not a compromise — but it should be discussed openly with the treating oncologist, who can explain which agent is best suited to your stage, mutation status, and prior treatments.

One important note: for patients with BRAF V600 mutations, targeted therapy (dabrafenib plus trametinib, or encorafenib plus binimetinib) may be recommended instead of or alongside immunotherapy. Chinese hospitals have full access to these agents as well.

How to Verify a Hospital's Melanoma Expertise

Not every hospital that advertises "cancer treatment" is qualified to manage melanoma well. Here is what to check before committing:

1. Is there a dedicated melanoma or melanoma-sarcoma unit? Ask directly. A general oncology department that occasionally treats melanoma is not the same as a specialized program.

2. Does the hospital run its own BRAF/NRAS/KIT mutation testing? If it has to outsource molecular testing, staging may be delayed and treatment decisions less precise.

3. Are there active clinical trials for melanoma? Trial participation signals genuine research engagement and often gives access to newer agents.

4. Does the team publish in peer-reviewed journals? You can search PubMed for the hospital's name plus "melanoma." A track record of publications is a strong signal.

5. Is there an international patient department with English-speaking staff? This matters enormously for communication, consent, and follow-up coordination.

This is exactly the kind of verification we do before recommending any hospital. You can read about our process on our hospital vetting page, or explore how the full treatment journey works on our patient journey page.

What a Melanoma Treatment Trip to China Looks Like

Most international patients follow a predictable sequence. It usually begins with a remote second opinion: you send pathology slides, imaging, and medical records, and a Chinese melanoma specialist reviews them and confirms diagnosis, staging, and a proposed plan. This step alone often saves patients from unnecessary travel — or, occasionally, reveals that a different treatment path is better.

If you decide to proceed, the typical timeline is:

• Week 1: Arrival, in-person consultation, repeat imaging and blood work, final treatment plan
• Week 2: Surgery (wide excision, SLNB, or lymph node dissection) or first immunotherapy infusion
• Week 3: Post-operative recovery, pathology review, discharge planning
• Ongoing: Immunotherapy continued at home where feasible, with periodic follow-up in China or locally

For patients on immunotherapy, one common and cost-effective approach is to receive the first one or two infusions in China, then continue the same drug at home under local supervision. Your Chinese oncologist can provide a detailed treatment letter for your home physician.

Practical Considerations for International Patients

Visa: Most patients travel on a standard tourist (L) or medical (M/S2) visa. Chinese hospitals can issue an invitation letter to support your application — we help coordinate this as part of our service.

Language: Top-tier hospitals have English-speaking international departments, but day-to-day interactions (nursing, pharmacy, scheduling) may still require a translator. We arrange medical interpreters where needed.

Accommodation: Most major cancer centers are located in Beijing, Shanghai, and Guangzhou, all with abundant short-term housing near the hospital. Expect USD 60–150 per night for comfortable accommodation near the hospital.

Follow-up: Plan for at least one follow-up visit within 3–6 months. Many patients combine this with a short holiday, which helps make the trip feel less clinical.

Records: Bring all original pathology slides if possible. Chinese pathologists can re-review them, which sometimes changes the diagnosis or staging in meaningful ways.

Frequently Asked Questions

What are the best hospitals in China for melanoma treatment in 2026?

Leading centers include Peking Union Medical College Hospital, Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center, Beijing Cancer Hospital, and Zhongshan Hospital. These combine high-volume surgical oncology, dermatopathology expertise, and full access to PD-1 inhibitors.

How much does melanoma treatment cost in China compared with the US?

Surgery plus one year of immunotherapy in China typically runs USD 20,000–45,000, versus USD 180,000–350,000 in the US before insurance. Overall savings are usually 70–85%.

Do Chinese hospitals offer the same immunotherapy drugs as the US?

Yes — pembrolizumab, nivolumab, and ipilimumab are all available, along with domestically developed PD-1 inhibitors like toripalimab and sintilimab that have comparable efficacy in published trials.

How long does a melanoma treatment trip to China take?

Most patients plan 2–3 weeks for initial workup, surgery, and recovery. Immunotherapy patients often return home after the first infusion and continue treatment locally.

Is it safe for international patients to receive melanoma care in China?

China's top-tier cancer centers are accredited, publish internationally, and treat high volumes of melanoma patients. Safety depends on choosing the right hospital and department — independent vetting is essential.

Can I get a second opinion from a Chinese melanoma specialist before traveling?

Yes. Many top centers offer remote second opinions based on pathology reports, imaging, and medical records, letting you confirm diagnosis and plan before committing to travel.

Related Reading

• Esophageal Cancer Treatment: Best Hospitals in China 2026
• China vs South Korea: Surgery Costs, Hospitals, and Recovery
• Getting a Remote Second Opinion Online: How It Works